Literature DB >> 2831385

Purification and partial characterization of poliovirus protease 2A by means of a functional assay.

H König1, B Rosenwirth.   

Abstract

The purification of poliovirus protease 2A from infected cells by a functional assay is described. A small synthetic peptide was cleaved specifically by an esterase present in poliovirus-infected cells. Since the enzyme proved extremely unstable in crude extracts a rapid and efficient purification procedure had to be developed. By treatment with different detergents followed by high-speed centrifugation, the esterase activity was separated from inactivating cellular enzymes and was solubilized. Purification to more than 90% homogeneity could be achieved by a single chromatography step, namely, by gel filtration through Superose 12 under fast-protein liquid chromatography conditions. The esterase activity was associated with a protein of 17,000 daltons and copurified with poliovirus protein 2A. Furthermore, antibodies to 2A specifically precipitated the esterase activity. Thus, the esterase was identified as poliovirus protease 2A. Inhibition studies with known protease inhibitors revealed that 2A is probably a sulfhydryl protease. Of the metal ions tested, only zinc exerted significant inhibitory effects. The esterase activity was optimal near neutral pH and had an extremely short half-life at physiological temperatures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831385      PMCID: PMC253133          DOI: 10.1128/JVI.62.4.1243-1250.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Rhinoviruses.

Authors:  E J Stott; R A Killington
Journal:  Annu Rev Microbiol       Date:  1972       Impact factor: 15.500

2.  Expression of animal virus genomes.

Authors:  D Baltimore
Journal:  Bacteriol Rev       Date:  1971-09

3.  Polypeptide cleavages in the formation of poliovirus proteins.

Authors:  M F Jacobson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

4.  Specific cleavage of viral proteins as steps in the synthesis and maturation of enteroviruses.

Authors:  J J Holland; E D Kiehn
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

5.  The activation reaction of papain.

Authors:  L A Sluyterman
Journal:  Biochim Biophys Acta       Date:  1967-07-11

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses.

Authors:  G Werner; B Rosenwirth; E Bauer; J M Seifert; F J Werner; J Besemer
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

8.  Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A.

Authors:  R E Lloyd; H Toyoda; D Etchison; E Wimmer; E Ehrenfeld
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

9.  Polyadenylic acid at the 3'-terminus of poliovirus RNA.

Authors:  Y Yogo; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

10.  Processing of adenovirus 2-induced proteins.

Authors:  C W Anderson; P R Baum; R F Gesteland
Journal:  J Virol       Date:  1973-08       Impact factor: 5.103

View more
  16 in total

1.  Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2A protease.

Authors:  Nisrine Falah; Sébastien Violot; Didier Décimo; Fatma Berri; Marie-Laure Foucault-Grunenwald; Théophile Ohlmann; Isabelle Schuffenecker; Florence Morfin; Bruno Lina; Béatrice Riteau; Jean-Claude Cortay
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity.

Authors:  E E Wyckoff; R E Lloyd; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220.

Authors:  C U Hellen; M Fäcke; H G Kräusslich; C K Lee; E Wimmer
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 4.  Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.

Authors:  W G Dougherty; B L Semler
Journal:  Microbiol Rev       Date:  1993-12

5.  Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.

Authors:  J E Jewell; L A Ball; R Rueckert
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  Nucleocytoplasmic traffic disorder induced by cardioviruses.

Authors:  Peter V Lidsky; Stanleyson Hato; Maryana V Bardina; Alexei G Aminev; Ann C Palmenberg; Eugene V Sheval; Vladimir Y Polyakov; Frank J M van Kuppeveld; Vadim I Agol
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors.

Authors:  A Molla; C U Hellen; E Wimmer
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores.

Authors:  George A Belov; Peter V Lidsky; Olga V Mikitas; Denise Egger; Konstantin A Lukyanov; Kurt Bienz; Vadim I Agol
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications.

Authors:  J F Bazan; R J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli.

Authors:  J C Alvey; E E Wyckoff; S F Yu; R Lloyd; E Ehrenfeld
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.